Genetic Signatures Ltd (GSS) — Cash Flow Reinvestment Rate

Latest as of June 2022: 1.32x

Genetic Signatures Ltd (GSS) has a Cash Flow Reinvestment Rate of 1.32x as of June 2022, reinvesting AU$2.55 Million (capex AU$2.55 Million ) from operating cash flow of AU$1.93 Million. See Genetic Signatures Ltd (GSS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.32x

(Capex + Investments) / Operating CF

Total Reinvested

AU$2.55 Million

Capex + Investments

Operating Cash Flow

AU$1.93 Million

AUD

Capital Expenditures

AU$2.55 Million

AUD

Genetic Signatures Ltd Cash Flow Reinvestment Rate (2021–2022)

Historical reinvestment intensity for Genetic Signatures Ltd across 2 annual periods. For the full cash flow conversion analysis, see Genetic Signatures Ltd cash flow conversion.

Annual Cash Flow Reinvestment Rate for Genetic Signatures Ltd (2021–2022)

Year-by-year capital reinvestment analysis for Genetic Signatures Ltd. See GSS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2022	0.61x	AU$5.98 Million	AU$9.81 Million	AU$2.99 Million	▼ -74.3%
2021	2.37x	AU$9.96 Million	AU$4.20 Million	AU$4.98 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow